Long-term non-interventional monitoring of patients newly diagnosed with bronchogenic carcinoma (LUCAS)

Study identification

• EU PAS number:
  EUPAS25626
• Study ID:
  43265
• Official title and acronym:
  Long-term non-interventional monitoring of patients newly diagnosed with bronchogenic carcinoma (LUCAS)
• DARWIN EU® study:
  No
• Study countries:
  Czechia
• Study description:
  Long-term non-interventional monitoring of newly diagnosed patients with bronchogenic carcinoma and their follow-up of up to 5 years. Epidemiology, diagnosis and treatment patterns will be monitored and evaluated.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Czech Medical Association of J. E. Purkyně

Faculty hospital Olomouc Olomouc, Faculty hospital Hradec Kralove Hradec Kralove, Faculty hospital Motol Praha Praha, Faculty hospital Brno Brno, Faculty hospital Plzen Plzen, Faculty hospital Bulovka Praha

Study timelines

Date when funding contract was signed

Planned:31/05/2018

Actual:12/09/2018

Study start date

Planned:01/06/2018

Actual:01/06/2018

Data analysis start date

Planned:01/01/2019

Date of interim report, if expected

Planned:31/12/2024

Date of final study report

Planned:28/02/2025

Sources of funding

Pharmaceutical company and other private sector 

Other

More details on funding

Roche, Takeda, MSD, Boehringer Ingelheim, Pfizer, BMS, Astra Zeneca, Sotio, Novartis, Celgene, UJV, Pneumoftizeology society of the Czech Medical Association of J. E. Purkyně

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable